| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Karen Aboody | Q90051514 |
| P2093 | author name string | Joseph Najbauer | |
| Richard T Frank | |||
| P2860 | cites work | Mesenchymal stem cells modified with a single-chain antibody against EGFRvIII successfully inhibit the growth of human xenograft malignant glioma | Q28473229 |
| Mesenchymal stem cells in health and disease | Q29614296 | ||
| Neural stem cells as a novel platform for tumor-specific delivery of therapeutic antibodies | Q33519052 | ||
| Genetic modification of mesenchymal stem cells to express a single-chain antibody against EGFRvIII on the cell surface | Q33892058 | ||
| Arming antibodies: prospects and challenges for immunoconjugates | Q34449555 | ||
| Strategies and new developments in the generation of patient-specific pluripotent stem cells | Q34764937 | ||
| Potent antibody therapeutics by design | Q36452621 | ||
| Stem and progenitor cell-mediated tumor selective gene therapy | Q37120161 | ||
| Human neural stem cells genetically modified to overexpress Akt1 provide neuroprotection and functional improvement in mouse stroke model | Q37184529 | ||
| Tumor immunotherapy using gene-modified human mesenchymal stem cells loaded into synthetic extracellular matrix scaffolds. | Q37312523 | ||
| Mesenchymal stem cells: flip side of the coin | Q37390208 | ||
| Down-regulation of MHC class I expression in human neuronal stem cells using viral stealth mechanism | Q38515633 | ||
| Novel method for visualizing and modeling the spatial distribution of neural stem cells within intracranial glioma | Q39180978 | ||
| Mesenchymal stem cells protect breast cancer cells through regulatory T cells: role of mesenchymal stem cell-derived TGF-beta | Q39716192 | ||
| Neural stem cell tropism to glioma: critical role of tumor hypoxia. | Q39906167 | ||
| Neural stem cell targeting of glioma is dependent on phosphoinositide 3-kinase signaling | Q40002631 | ||
| Targeting tumor stroma using engineered mesenchymal stem cells reduces the growth of pancreatic carcinoma | Q43262131 | ||
| Sustained survival of xenografted human neural stem/progenitor cells in experimental brain trauma despite discontinuation of immunosuppression. | Q46953757 | ||
| Neural progenitor cells lack immunogenicity and resist destruction as allografts. | Q47795672 | ||
| Allorecognition of human neural stem cells by peripheral blood lymphocytes despite low expression of MHC molecules: role of TGF-beta in modulating proliferation. | Q48092257 | ||
| Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents | Q64379193 | ||
| Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts | Q73791469 | ||
| Absence of major histocompatibility complex class I on neural stem cells does not permit natural killer cell killing and prevents recognition by alloreactive cytotoxic T lymphocytes in vitro | Q80984780 | ||
| Monoclonal antibody therapy of cancer | Q81189032 | ||
| Improved graft mesenchymal stem cell survival in ischemic heart with a hypoxia-regulated heme oxygenase-1 vector | Q81297170 | ||
| P275 | copyright license | Creative Commons Attribution 2.5 Generic | Q18810333 |
| P433 | issue | 11 | |
| P921 | main subject | stem cell | Q48196 |
| antibody | Q79460 | ||
| neoplasm | Q1216998 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 2084-2087 | |
| P577 | publication date | 2010-11-01 | |
| P1433 | published in | Stem Cells | Q15724411 |
| P1476 | title | Concise review: stem cells as an emerging platform for antibody therapy of cancer | |
| P478 | volume | 28 |
| Q38227489 | Advances in stem cells, induced pluripotent stem cells, and engineered cells: delivery vehicles for anti-glioma therapy |
| Q26830028 | Cancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers |
| Q24615515 | Cell-based therapy for neural disorders--anticipating challenges |
| Q35167725 | Directional migration of adult hematopoeitic progenitors to C6 glioma in vitro |
| Q40686919 | Engineered Mesenchymal Cells Improve Passive Immune Protection Against Lethal Venezuelan Equine Encephalitis Virus Exposure |
| Q92349932 | Established and Emerging Strategies for Drug Delivery Across the Blood-Brain Barrier in Brain Cancer |
| Q37856565 | Genetic therapy for the nervous system |
| Q36127425 | Longitudinal evaluation of MPIO-labeled stem cell biodistribution in glioblastoma using high resolution and contrast-enhanced MR imaging at 14.1 tesla |
| Q37396577 | Neural stem cell-mediated enzyme/prodrug therapy for glioma: preclinical studies |
| Q37874445 | Non-hematopoietic stem cells as factories for in vivo therapeutic protein production. |
| Q39275884 | Optical imaging of progenitor cell homing to patient-derived tumors |
| Q38299631 | Regulation of subventricular zone-derived cells migration in the adult brain |
| Q42267793 | Targeting Malignant Brain Tumors with Antibodies |
| Q38213836 | Therapeutic cell carriers: a potential road to cure glioma |
| Q45876898 | Tumor tropism of intravenously injected human-induced pluripotent stem cell-derived neural stem cells and their gene therapy application in a metastatic breast cancer model. |
| Q37096574 | Tumourigenicity and Immunogenicity of Induced Neural Stem Cell Grafts Versus Induced Pluripotent Stem Cell Grafts in Syngeneic Mouse Brain |
Search more.